X-52866526-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_133179.3(XAGE3):c.94G>A(p.Glu32Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000456 in 1,097,663 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_133179.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XAGE3 | NM_133179.3 | c.94G>A | p.Glu32Lys | missense_variant | 3/5 | ENST00000346279.4 | NP_573440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XAGE3 | ENST00000346279.4 | c.94G>A | p.Glu32Lys | missense_variant | 3/5 | 1 | NM_133179.3 | ENSP00000303061.3 | ||
XAGE3 | ENST00000375491.7 | c.94G>A | p.Glu32Lys | missense_variant | 3/5 | 1 | ENSP00000364640.3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182934Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67482
GnomAD4 exome AF: 0.00000456 AC: 5AN: 1097663Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 1AN XY: 363071
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.94G>A (p.E32K) alteration is located in exon 3 (coding exon 2) of the XAGE3 gene. This alteration results from a G to A substitution at nucleotide position 94, causing the glutamic acid (E) at amino acid position 32 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at